COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of life for patients. These devices range from inhalers to ...

Patterns of Asthma Medication Use and Hospital Discharges in Māori in Aotearoa New Zealand highlight a 32% drop in asthma hospitalisations for Māori ...

Asthma hospitalisations among Māori have decreased, according to a new study, but experts warn there is still a long way to ...

Inhaled insulin is not recommended for the treatment of diabetic ketoacidosis or in patients who smoke or have recently stopped smoking. Warning: Risk for acute bronchospasm in patients with chronic ...

Quintupling the ICS dose in children age 5 to 11 who lose asthma control may worsen outcomes in those with a higher socio-economic status.

Keltic Pharma Therapeutics has been awarded SMART Grant funding to develop its work tackling asthma and other inflammatory ...

Call planned today at 8:30 a.m. (ET) to discuss company's diabetes program progression The INHALE-1 study is a 26-week, ...

The news followed an investigation by POLITICO's E&E News into climate-friendly inhalers and how drug giants are developing ...

Americans with asthma and 16 million Americans with COPD need inhalers to breathe. Vermont Business Magazine Sen. Bernie Sanders (I-Vermont), Chairman of the Senate Com ...

Winter can be a challenging season for those living with asthma, as the cold air, indoor allergens, and seasonal illnesses ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...